These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 13556698)

  • 1. [Dihydrostreptomycin pantothenate & its tolerance in the treatment of pulmonary tuberculosis].
    VERAN P; BARON F; MOIGNETEAU C; TRICHEREAU R; DELHUMEAU G; BEAUPERE J
    Therapie; 1958; 13(2):220-6. PubMed ID: 13556698
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical studies with dihydrodesoxystreptomycin; preliminary report.
    OBUCHI S; SAITO T; IMAGAWA Y; NAKAGAWA K; NAGANUMA H; FUJITA S; KAMADA K; NAGASAWA J; ISHII K; MURATA T; GOMI J; BABA H
    J Antibiot (Tokyo); 1958 Sep; 11(9):199-201. PubMed ID: 13610776
    [No Abstract]   [Full Text] [Related]  

  • 3. Auditory nerve toxicity of dihydrostreptomycin sulfate and dihydrostreptomycin pantothenate.
    HEWITT WL; GLORIG A; FINEGOLD S
    Antibiot Annu; 1957-1958; 5():609-13. PubMed ID: 13521866
    [No Abstract]   [Full Text] [Related]  

  • 4. [Technic of intravenous PAS-streptomycin-pantothenate treatment in tuberculosis].
    KUNTZ E
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1957; 117(2):259-64. PubMed ID: 13522541
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preliminary experience with intramuscular and intravenous didrothenat in the treatment of pulmonary tuberculosis].
    PAPPA E
    Medizinische; 1956 Jul; 7(29-30):1040-1. PubMed ID: 13358440
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tolerance of dihydrostreptomycin-pantothenate during a clinical test].
    THIBIER R; VIVIEN JN; LEPEUPLE A; ARNAUD G; ESTELLON P; ASTRIE N
    Rev Tuberc; 1957 Jun; 21(6):666-73. PubMed ID: 13485835
    [No Abstract]   [Full Text] [Related]  

  • 7. [Value & tolerance of dihydrostreptomycin pantothenate in the treatment of pulmonary tuberculosis].
    VERAN P; BARON F; MOIGNETEAU C; DELHUMEAU G; BEAUPERE J
    Sem Hop; 1957 Sep 6-10; 33(51-52):3043-7. PubMed ID: 13486092
    [No Abstract]   [Full Text] [Related]  

  • 8. [Remarkable tolerance of dihydrostreptomycin (from hospital statistics)..].
    BRUN J; VIALLIER J; DUMONT
    Lyon Med; 1952 Mar; 186(13):193-5. PubMed ID: 14947135
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dihydrostreptomycin in pulmonary tuberculosis].
    Dia Med; 1951 Sep; 23(64):2861; passim. PubMed ID: 14879647
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduced neurotoxicity in the treatment of tuberculosis by combined streptomycin-dihydrostreptomycin therapy.
    HECK WE; LYNCH WJ; GRAVES HL
    Acta Otolaryngol; 1953; 43(4-5):416-20. PubMed ID: 13104135
    [No Abstract]   [Full Text] [Related]  

  • 11. Purified dihydrostreptomycin.
    MAHADY SC; ARMSTRONG FL; MONROE J
    Am Rev Tuberc; 1956 May; 73(5):776-8. PubMed ID: 13313964
    [No Abstract]   [Full Text] [Related]  

  • 12. [Toxic effect of dihydrostreptomycin on acoustic function].
    BENTZEN O; FILLING S; JELNES K; HANSEN MS
    Nord Med; 1953 May; 49(21):755-7. PubMed ID: 13072973
    [No Abstract]   [Full Text] [Related]  

  • 13. Streptomycin and dihydrostreptomycin in the treatment of tuberculous empyema. I. Experimental studies of the drug concentrations attained with various vehicles.
    STAHLE I
    Am Rev Tuberc; 1952 Sep; 66(3):271-84. PubMed ID: 14952715
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hearing disorders after dihydrostreptomycin therapy].
    FALKENFLETH G
    Nord Med; 1952 Jul; 47(30):1033-7. PubMed ID: 14948106
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of extrapulmonary tuberculosis with didrothenate].
    REINHARD W; DUSBERG K
    Tuberkulosearzt; 1957 Feb; 11(2):93-6. PubMed ID: 13422650
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental and clinical study of various recently discovered antibacillary substances; dihydrostreptomycin and cycloserine panthothenates].
    TACQUET A; VOISIN C; GERNEZRIEUX C
    Therapie; 1956; 11(6):1054-62. PubMed ID: 13409317
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ototoxicity of dihydrostreptomycin and kanamycin. Comparative experimental study].
    Darrouzet J
    Rev Laryngol Otol Rhinol (Bord); 1967; 88(1):133-4. PubMed ID: 4174901
    [No Abstract]   [Full Text] [Related]  

  • 18. Dihydrostreptomycin and kanamycin ototoxicity. An experimental study by surface preparation technique.
    Kohonen A; Tarkkanen JV
    Laryngoscope; 1966 Oct; 76(10):1671-80. PubMed ID: 4162930
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cochleovestibular toxic manifestations of dihydrostreptomycin in renal patients].
    MELAMPI M
    Minerva Otorinolaringol; 1957; 7(1):1-5. PubMed ID: 13451428
    [No Abstract]   [Full Text] [Related]  

  • 20. [In vitro antituberculous activity of the dihydrostreptomycin salt of sulfoniazid (streptorilone)].
    VIALLIER J; CAYRE RM
    C R Seances Soc Biol Fil; 1958; 152(11):1501-3. PubMed ID: 13639410
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.